Skip to main content

Table 4 Antibiotics resistance among the major isolates

From: Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal

Antibiotic Klebsiella (N = 23) CONS (14) Enterobacter (N = 13) Acinetobacter (N = 8) Escherichia coli (N = 3) Serratia rubidaea (N = 3)
R/(R + S) R % R/(R + S) R % R/(R + S) R % R/(R + S) R % R/(R + S) R % R/(R + S) R %
Beta-lactam Antibiotics
 Oxacillin 6/6 100 8/10 80 3/3 100 2/2 100 1/1 100 1/2 50
 Cefotaxime 19/21 90.5 4/6 66.7 10/12 83.4 6/7 85.7 3/3 100 1/3 33.3
 Meropenem 0/18 0 4/5 80 2/10 20 4/7 57.1 2/3 66.7 0/3 0
 Pip-Taz 4/10 40 1/2 50 2/4 50 3/6 50 2/2 100 1/3 33.3
Non-beta-lactam Antibiotics
 Amikacin 12/21 57 5/10 50 0/1 0 7/7 100 3/3 100 1/3 33.3
 Gentamicin 15/20 75 7/12 58.3 5/13 38.5 5/7 71.4 2/3 66.7 1/3 33.3
 Chloramphenicol 13/20 65 5/11 45.5 8/13 61.5 7/7 100 3/3 100 3/3 100
 Ciprofloxacin 16/21 76.2 8/10 80 5/13 38.5 3/16 18.8 3/3 100 1/3 33.3
 Ofloxacin 13/18 72.2 8/12 66.7 1/12 8.3 4/6 66.7 3/3 100 1/3 33.3
 Linezolid 0/3 0 1/1 100 0/1 0
 Vancomycin 1/1 100 0/4 0 1/1 100 0/1 0
 Tigecycline 2/11 18.2 1/7 14.3 2/6 33.3 0/2 0 0/1 0
 Colistin 2/18 11.2 1/8 12.5 1/5 20 0/3 0 1/3 33.3
  1. CONS Coagulase negative staphylococi, Pip-Taz Piperacillin-Tazobactam, R Number of resistant isolates, R% Percentage of resistant isolates, S Number of susceptible isolates, [−] Not tested